100 results
424B4
RVPH
Reviva Pharmaceuticals Holdings Inc.
13 Feb 24
Prospectus supplement with pricing info
5:00pm
at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which … of directors to determine whether a nomination or any business proposed to be brought before a special meeting of the stockholders was made
424B5
RVPH
Reviva Pharmaceuticals Holdings Inc.
17 Nov 23
Prospectus supplement for primary offering
4:03pm
is approved by the board and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least … board of directors or a committee of our board of directors to determine whether a nomination or any business proposed to be brought before a special
424B3
yr67um5
5 Apr 23
Prospectus supplement
5:10pm
POS AM
k3u00oe86 u9
30 Mar 23
Prospectus update (post-effective amendment)
8:06am
424B4
qcodmkqxzhv2j cwzdx
18 Oct 22
Prospectus supplement with pricing info
7:01am
424B5
arvs1juoc8j srp1atc4
7 Sep 22
Prospectus supplement for primary offering
4:17pm
424B3
5bnayy
23 Mar 22
Prospectus supplement
4:15pm
424B3
e0zxug
23 Mar 22
Prospectus supplement
4:15pm
POS AM
b12sl95w3
18 Mar 22
Prospectus update (post-effective amendment)
5:01pm
POS AM
qpag6mn5f
18 Mar 22
Prospectus update (post-effective amendment)
5:00pm
424B3
rmae3bet z5zw8ylfx
2 Feb 22
Prospectus supplement
4:57pm
424B3
pr96s50a88u
2 Feb 22
Prospectus supplement
4:52pm
S-3
7vjz9o
26 Jan 22
Shelf registration
4:15pm